FDA Takes Enforcement Action Against CardioMEMS For Alleged Clinical Trial Violations

A warning letter cites violations related to the pivotal trial of the firm's Champion HF implantable heart failure monitor.

FDA put its long-simmering concerns about CardioMEMS' CHAMPION clinical trial into legal form with a warning letter

citing the firm for numerous regulatory violations.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Compliance

More from Policy & Regulation